Hyloris Adds Aguettant Deals For Maxigesic IV In Europe
Partner AFT Signs Licensing Agreements In Eight European Markets
Hyloris has secured licensing deals with Aguettant for its Maxigesic IV combination of paracetamol and ibuprofen in a further eight European markets through partner AFT Pharmaceuticals.
